IL326463A - צורות גבישיות של מעכב pi3k ושימושים בו - Google Patents
צורות גבישיות של מעכב pi3k ושימושים בוInfo
- Publication number
- IL326463A IL326463A IL326463A IL32646326A IL326463A IL 326463 A IL326463 A IL 326463A IL 326463 A IL326463 A IL 326463A IL 32646326 A IL32646326 A IL 32646326A IL 326463 A IL326463 A IL 326463A
- Authority
- IL
- Israel
- Prior art keywords
- same
- crystalline forms
- pi3k inhibitor
- pi3k
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363532700P | 2023-08-15 | 2023-08-15 | |
| PCT/US2024/042221 WO2025038698A1 (en) | 2023-08-15 | 2024-08-14 | Crystalline forms of a pi3k inhibitor and uses of same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326463A true IL326463A (he) | 2026-04-01 |
Family
ID=92632772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326463A IL326463A (he) | 2023-08-15 | 2024-08-14 | צורות גבישיות של מעכב pi3k ושימושים בו |
Country Status (7)
| Country | Link |
|---|---|
| AR (1) | AR133554A1 (he) |
| AU (1) | AU2024323620A1 (he) |
| CO (1) | CO2026001466A2 (he) |
| IL (1) | IL326463A (he) |
| MX (1) | MX2026001800A (he) |
| TW (1) | TW202509025A (he) |
| WO (1) | WO2025038698A1 (he) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025240847A1 (en) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Ras inhibitors |
| US20250375445A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022265993A1 (en) | 2021-06-14 | 2022-12-22 | Scorpion Therapeutics, Inc. | Urea derivatives which can be used to treat cancer |
| CN120529906A (zh) * | 2022-10-31 | 2025-08-22 | 蝎子疗法股份有限公司 | 用于治疗癌症的组合疗法 |
-
2024
- 2024-08-14 IL IL326463A patent/IL326463A/he unknown
- 2024-08-14 WO PCT/US2024/042221 patent/WO2025038698A1/en active Pending
- 2024-08-14 TW TW113130461A patent/TW202509025A/zh unknown
- 2024-08-14 AU AU2024323620A patent/AU2024323620A1/en active Pending
- 2024-08-15 AR ARP240102160A patent/AR133554A1/es unknown
-
2026
- 2026-02-09 CO CONC2026/0001466A patent/CO2026001466A2/es unknown
- 2026-02-13 MX MX2026001800A patent/MX2026001800A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202509025A (zh) | 2025-03-01 |
| WO2025038698A9 (en) | 2025-06-05 |
| AR133554A1 (es) | 2025-10-08 |
| CO2026001466A2 (es) | 2026-03-05 |
| AU2024323620A1 (en) | 2026-02-19 |
| MX2026001800A (es) | 2026-03-02 |
| WO2025038698A1 (en) | 2025-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL326463A (he) | צורות גבישיות של מעכב pi3k ושימושים בו | |
| IL310234A (he) | מלחים ותצורות מצב מוצק של תרכובת מעכב kif18a | |
| IL326350A (he) | בנזופירידינונים ובנזופירימידינונים כמעכבי pi3k | |
| IL326137A (he) | מעכבי pi3k | |
| AU2024314618A1 (en) | Pi3k inhibitors and use thereof | |
| IL321053A (he) | צורות גבישיות של מעכב her2 | |
| IL321357A (he) | מעכבי kif18a ושימושים שלהם | |
| EP4244231A4 (en) | CRYSTALLINE SOLID MEGLUMIN SALT INHIBITOR OF BCL AND METHOD OF PREPARING AND USING THE SAME | |
| IL325861A (he) | צורות גבישיות של מעכב מנין | |
| CA3264917A1 (en) | KIF18A INHIBITORS AND THEIR USES | |
| IL321007A (he) | צורות גבישיות של מעכב פיפרידין של תפקוד slc6a19 | |
| EP4181921A4 (en) | CRYSTALLINE FORMS OF A SELECTIVE C-KIT KINASE INHIBITOR | |
| IL305791A (he) | מלח וצורות מוצקות של מעכב קינאז | |
| IL319006A (he) | צורות גבישיות של מעכב pcsk9, הרכבים ושימושים | |
| HK40121198A (en) | Crystalline forms and salts of a pi3k inhibitor and methods of making and methods of use thereof | |
| AU2021368138A9 (en) | Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof | |
| HUE073161T2 (hu) | Jak-gátló kristályos formája és alkalmazása | |
| HK40128961A (zh) | Parp1抑制剂的结晶形式 | |
| HK40109581A (en) | Salts and solid state forms of a kif18a inhibitor compound | |
| CA3288716A1 (en) | Crystalline forms of a ras inhibitor | |
| HK40117256A (en) | Crystalline forms and salt forms of a kinase inhibitor | |
| HK40086278A (en) | Crystalline forms of a tyk2 inhibitor | |
| HK40091715A (en) | Crystalline forms of a cd73 inhibitor and uses thereof | |
| IL326563A (he) | צורות גבישיות של מעכב bet | |
| GB202101735D0 (en) | Solid forms of a plasma kallikrein inhibitor and salts thereof |